Japan Tissue Engineering Co., Ltd. develops, manufactures, and sells regenerative medicines in Japan. It develops, manufactures, and sells tissue-engineered medical and related products. The company offers autologous cultured epidermis, cartilage, and corneal epithelium to medical institutions for the purpose of medical treatment. Its tissue-engineered medical products are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured, and then transplanted back to the same patient. The company is also involved in the research and development of human 3-dimensional cultured tissue models for use in the development of drugs for external use and cosmetics, as well as for various forms of research that makes use of skin and cornea. Japan Tissue Engineering Co., Ltd. was founded in 1999 and is headquartered in Gamagori, Japan.
japan tissue engineering co
(7774:Tokyo Stock Exchange)
Phone: 81 533 66 2020
Fax: 81 533 66 2019www.jpte.co.jp
|No competitor information is available for 7774.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact JAPAN TISSUE ENGINEERING CO, please visit www.jpte.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.